NEW YORK (GenomeWeb News) – Biotechnology company Antigen Discovery said today it has received a three-year, $2.5 million award from the National Institutes of Health to use its proteome microarray technology to develop companion diagnostics for Sanaria's malaria products in human trials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.